🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mangaiarkarasi Asokan

National Institute of Allergy and Infectious Diseases

ORCID: 0000-0001-9294-1833

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies”.

Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

mAbs(2020)10.1080/19420862.2020.1836719

N/A

0.345DataRank · unranked

9 citations

Mangaiarkarasi Asokan, Vera B. Ivleva, Amarendra Pegu, Eun Sung Yang, Baoshan Zhang +14 more

Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

JCI Insight(2020)10.1172/jci.insight.143958

N/A

0DataRank · unranked

50 citations

Lais Da Silva Pereira, Keenan Ernste, Yevel Flores-García, Azza H. Idris, Mangaiarkarasi Asokan +11 more

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention

mAbs(2021)10.1080/19420862.2021.1946918

N/A

0DataRank · unranked

25 citations

Mangaiarkarasi Asokan, Jason Gorman, Baoshan Zhang, Qingbo Liu, Mark K. Louder +12 more

Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging

Journal of Clinical Investigation(2021)10.1172/jci151632

N/A

0DataRank · unranked

7 citations

Giulia Fabozzi, Kylie March, Mangaiarkarasi Asokan, Cassandra Almasri, Jonathan Fintzi +11 more

Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys

Cell Reports(2022)10.1016/j.celrep.2021.110199

N/A

0DataRank · unranked

31 citations

Ling Xu, Megan Demouth, Giulia Fabozzi, Kylie March, Cassandra Almasri +33 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Scientific Reports(2022)10.1038/s41598-022-22435-2

N/A

0DataRank · unranked

14 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Research Square(2022)10.21203/rs.3.rs-1534769/v1

N/A

0DataRank · unranked

0 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

mAbs(2023)10.1080/19420862.2023.2165390

N/A

0DataRank · unranked

14 citations

Jason Gorman, Young Do Kwon, Amarendra Pegu, Cara W. Chao, Tracy Liu +23 more

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain

mAbs(2023)10.1080/19420862.2023.2223350

N/A

0DataRank · unranked

9 citations

Amarendra Pegu, Eun Sung Yang, Baoshan Zhang, Michael F. Bender, Mangaiarkarasi Asokan +14 more

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Nature Communications(2024)10.1038/s41467-024-51848-y

N/A

0DataRank · unranked

12 citations

Giulia Fabozzi, Slim Fourati, Xuejun Chen, Cuiping Liu, David R. Ambrozak +29 more

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2008236117

N/A

0DataRank · unranked

88 citations

Joana Dias, Cuiping Liu, Anna A Maximova, Keenan Ernste, Amarendra Pegu +24 more

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study

The Lancet Regional Health - Southeast Asia(2024)10.1016/j.lansea.2024.100361

N/A

0DataRank · unranked

9 citations

Roshni Florina Joan, Sudhir Babji, Girish Dayma, Prajitha Nadukkandy, Vinutha Subrahmanyam +58 more